New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 11, 2013
10:14 EDTALNY, TS, LUFK, ESV, BAS, BHI, LNKD, NR, AMGN, KEY, GMCR, KMB, SCHW, FOSL, ELN, PDCE, PMC, POWI, PRI, SIAL, S, CMAOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Alnylam (ALNY) downgraded to Hold from Buy at MLV Equity... Charles Schwab (SCHW) downgraded to Sell from Neutral at Citigroup... Elan (ELN) downgraded to Neutral from Buy at UBS... Fossil (FOSL) downgraded to Hold from Buy at Benchmark Co... PDC Energy (PDCE) downgraded to Neutral from Buy at SunTrust... PharMerica (PMC) downgraded to Sector Perform from Outperform at RBC Capital... Power Integrations (POWI) downgraded to Hold from Buy at Deutsche Bank... Primerica (PRI) downgraded to Market Perform from Outperform at Keefe Bruyette... Sigma-Aldrich (SIAL) downgraded to Sell from Neutral at UBS... Sprint (S) downgraded to Neutral from Overweight at Atlantic Equities... Kimberly Clark (KMB) downgraded to Underweight from Equal Weight at Barclays... Green Mountain (GMCR) downgraded to Neutral from Buy at Dougherty... Tenaris (TS) downgraded to Hold from Buy at Dahlman Rose... Lufkin (LUFK) downgraded to Hold from Buy at Dahlman Rose... Ensco (ESV) downgraded to Hold from Buy at Dahlman Rose... Basic Energy (BAS) downgraded to Hold from Buy at Dahlman Rose... Baker Hughes (BHI) downgraded to Hold from Buy at Dahlman Rose... LinkedIn (LNKD) downgraded to Market Perform from Outperform at Northland Securities... Newpark Resources (NR) downgraded to Hold from Buy at Dahlman Rose... Amgen (AMGN) downgraded to Market Perform from Outperform at William Blair... KeyCorp (KEY) downgraded at Stifel Nicolaus... Comerica (CMA) downgraded at Stifel Nicolaus.
News For ALNY;SCHW;FOSL;ELN;PDCE;PMC;POWI;PRI;SIAL;S;KMB;GMCR;TS;LUFK;ESV;BAS;BHI;LNKD;NR;AMGN;KEY;CMA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>
October 15, 2014
06:36 EDTKEYKeyCorp reports Q3 EPS 23c, consensus 26c
Reports Q3 book value per share $11.77. Reports Q3 tier 1 capital ratio 12%. Reports Q3 net charge-offs 0.22%. Key incurred $35M, or 3c per common share, of costs related to both its efficiency initiative and a pension settlement charge, compared to $41M, or 3c per common share, during 3Q13.
06:32 EDTBHICiti rolls out Oil Services coverage, recommends two pair trades
Subscribe for More Information
06:14 EDTGMCRKeurig Green Mountain implied volatility of 40 at lower end of index mean range
Subscribe for More Information
06:07 EDTBHIBaker Hughes initiated with a Buy at Citigroup
Subscribe for More Information
October 14, 2014
15:29 EDTKEYNotable companies reporting before tomorrow's open
Subscribe for More Information
11:23 EDTAMGNBIND Therapeutics and The Conference Forum hold a conference
Subscribe for More Information
11:21 EDTFOSLFossil initiated with a Buy at Standpoint Research
Target $124.
10:01 EDTPDCEOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: AU Optronics (AUO) upgraded to Neutral from Sell at UBS... Antero Resources (AR) upgraded to Buy from Accumulate at KLR Group... BHP Billiton (BHP) upgraded to Neutral from Underperform at Credit Suisse... Bill Barrett (BBG) upgraded to Buy from Accumulate at KLR Group... BorgWarner (BWA) upgraded to Buy from Neutral at Goldman... CRH Plc. (CRH) upgraded to Buy from Neutral at Citigroup... Comstock Resources (CRK) upgraded to Buy from Accumulate at KLR Group... Cracker Barrel (CBRL) upgraded at Argus... Delphi Automotive (DLPH) upgraded to Buy from Neutral at Goldman... EOG Resources (EOG) upgraded at Bernstein... Eaton (ETN) upgraded to Overweight from Equal Weight at Barclays... Energizer (ENR) upgraded to Outperform from Market Perform at Wells Fargo... Energy Transfer Equity (ETE) upgraded to Outperform at RW Baird... Federal-Mogul (FDML) upgraded to Neutral from Sell at Goldman... Ford (F) upgraded to Neutral from Underperform at Buckingham... Gulfport Energy (GPOR) upgraded to Accumulate from Hold at KLR Group... Halcon Resources (HK) upgraded to Buy from Hold at KLR Group... HeartWare (HTWR) upgraded to Overweight from Neutral at Piper Jaffray... Helmerich & Payne (HP) upgraded to Outperform at FBR Capital... Legg Mason (LM) upgraded to Neutral from Underperform at BofA/Merrill... Level 3 (LVLT) upgraded to Buy from Hold at Gabelli... Magnum Hunter (MHR) upgraded to Buy from Hold at KLR Group... NetScout (NTCT) upgraded at DA Davidson... Netflix (NFLX) upgraded to Buy with $600 target at BTIG... Newfield Exploration (NFX) upgraded to Buy from Hold at KLR Group... Nielsen (NLSN) upgraded at Bernstein... Orbitz (OWW) upgraded to Outperform from Market Perform at FBR Capital... PDC Energy (PDCE) upgraded to Buy from Hold at KLR Group... Rackspace (RAX) upgraded to Buy from Hold at Evercore... Range Resources (RRC) upgraded to Accumulate from Hold at KLR Group... Rex Energy (REXX) upgraded to Buy from Accumulate at KLR Group... SM Energy (SM) upgraded to Buy from Accumulate at KLR Group... Sanchez Energy (SN) upgraded to Buy from Accumulate at KLR Group... Targa Resources (TRGP) upgraded to Buy from Accumulate at Tudor Pickering... Unilife (UNIS) upgraded to Buy from Neutral at Ladenburg... Universal Forest (UFPI) upgraded at Sterne Agee.
08:42 EDTPDCEPDC Energy upgraded to Buy from Hold at KLR Group
Subscribe for More Information
08:04 EDTALNYAlnylam presents new ALN-TTRsc Phase 1 trial data
Subscribe for More Information
07:59 EDTSCHWSchwab, Ameritrade look 'deeply undervalued,' says Deutsche Bank
Subscribe for More Information
07:54 EDTST-Mobile, Sprint risk turnover courting lower-credit subscribers, WSJ says
Subscribe for More Information
05:40 EDTALNYTekmira partner Alnylam reports positive clinical data for Patisiran study
Tekmira Pharmaceuticals (TKMR) reported that Alnylam Pharmaceuticals (ALNY) presented six-month clinical data for the ongoing Patisiran Phase II Open Label Extension, or OLE, study in patients with Familial Amyloidotic Polyneuropathy, or FAP. Patisiran is an RNAi therapeutic targeting transthyretin, or TTR, in development for the treatment of TTR-mediated amyloidosis, or ATTR, which is enabled by Tekmira's lipid nanoparticle, or LNP, technology. Alnylam presented data at the American Neurological Association's 2014 Annual Meeting. Results showed a mean 0.95 point decrease in modified Neuropathy Impairment Score at six months in 19 patients with mNIS+7 data available for the current analysis. This decrease in neuropathy progression compares favorably with the 7 to 10 point increase in mNIS+7 at six months that can be estimated from historical data sets in untreated FAP patients with similar baseline characteristics.
October 13, 2014
16:28 EDTALNYOn The Fly: Closing Wrap
Stocks on Wall Street spent most of today's quiet session see-sawing across the flat-line before dropping sharply in the final hour of trading and closing at their lows. The market opened in negative territory but soon made a move to the upside and appeared ready to break the recent market slide that has seen the S&P lose about 5% of its value. Before the averages gained significant steam, they reversed again and moved back into negative ground. The averages moved in a fairly narrow range for most of the afternoon, before accelerating to the downside with conviction in the final hour of trading. ECONOMIC EVENTS: In the U.S., no economic data of note was reported and banks and bond markets were closed in observance of the Columbus Day holiday. In China, the nation's customs administration reported a trade surplus of about $31B for September. Exports in the month increased 15.3% from a year earlier, beating expectations and making for the biggest monthly increase since February 2013. Imports rose 7%, significantly outpacing the consensus projection for a 2% decline. COMPANY NEWS: The Wall Street Journal reported that CSX (CSX) was approached by a larger rival, Canadian Pacific (CP), about a possible merger. However, Credit Suisse analyst Allison Landry wrote in a note to investors that a merger between the two would not be able to occur, due to high regulatory hurdles. Still, CSX rose $1.76, or 5.88%, to $31.70 following the Journal's report, while Canadian Pacific fell $4.40, or 2.32%, to $184.97... Shares of Fiat Chrysler Automobiles (FCAU) made their debut on the New York Stock Exchange and opened at $9 per share. The stock of the newly merged company closed trading down about 1% at $8.92... J.C. Penney (JCP) selected Marvin Ellison, who is currently executive vice president of stores at Home Depot (HD), to become its next CEO. The stock, which was also downgraded to Sell from Neutral at UBS this morning, spent much of the trading day in positive ground but moved lower late in the session and closed down 3c, or 0.42%, at $7.09. MAJOR MOVERS: Among the notable gainers was Alnylam (ALNY), which advanced $13.83, or 18.98%, to $86.68 after the company announced data from study of its treatment for patients with familial amyloidotic polyneuropathy and Piper Jaffray raised its price target on the stock to $133 from $101 citing the trial results. Among the noteworthy losers was AutoNation (AN), which fell $4.11, or 8.01%, to $47.21 after another company in the same sector, Lithia Motors (LAD), lowered its profit outlook for the third and fourth quarter and issued a lower than expected earnings forecast for fiscal 2015. Shares of Lithia, meanwhile, plunged $16.85, or 20.84%, to $64.01. Also lower were shares of GoPro (GPRO), which fell $8.38, or 9.85%, to $76.67 after a French journalist reported that the son of racing legend Michael Schumacher attributed the severity of his father's brain injury following a skiing accident on the GoPro camera mounted to his helmet. INDEXES: The Dow fell 223.03, or 1.35%, to 16,321.07, the Nasdaq dropped 62.58, or 1.46%, to 4,213.66, and the S&P 500 declined 31.39, or 1.65%, to 1,874.74.
09:44 EDTALNYAlnylam price target raised to $133 on positive Ph. 2 results at Piper Jaffray
Piper Jaffray raised Alnylam's price target to $133 from $101 following positive Phase 2 open-label extension study with patisiran in patients with familial amyloidotic polyneuropathy.
07:33 EDTALNYAmerican Neurological Association to hold annual meeting
ANA 2014: 139th Annual Meeting is being held in Baltimore on October 12-14.
07:26 EDTGMCRAB InBev has studied potential deal to acquire PepsiCo, Bloomberg says
Anheuser-Busch InBev (BUD), which has a history of growth via acquisition and has been speculated to be targeting peer SABMiller (SBMRY), has also studied whether a merger with PepsiCo (PEP) makes sense, according to Bloomberg, citing people familiar with the matter. The report added that one source said no talks between Anheuser-Busch and Pepsi are ongoing, no deal is imminent, and the scenario is among many that has been examined. The report also noted that Albert Fried views Monster Beverage (MNST) and Keurig Green Mountain (GMCR) as other suitable targets for AB InBev. Reference Link
07:12 EDTALNYOligonucleotide Therapeutics Society to hold annual meeting
Subscribe for More Information
06:44 EDTALNYAlnylam to host conference call
Subscribe for More Information
06:04 EDTALNYAlnylam's patisiran for polyneuropathy shows positive Phase 2 results
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use